AIM
GSK icon

Anchor Investment Management’s GSK GSK Stock Holding History

Anchor Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
33,440
-1,950
-6% -$106K 0.15% 138
2025
Q4 		$1.74M Sell
35,390
-510
-1% -$23.8K 0.14% 145
2025
Q3 		$1.55M Sell
35,900
-900
-2% -$35.2K 0.13% 154
2025
Q2 		$1.41M Sell
36,800
-4,108
-10% -$157K 0.12% 156
2025
Q1 		$1.58M Sell
40,908
-550
-1% -$20.1K 0.15% 145
2024
Q4 		$1.4M Sell
41,458
-3,660
-8% -$132K 0.13% 154
2024
Q3 		$1.84M Sell
45,118
-3,519
-7% -$144K 0.17% 131
2024
Q2 		$1.87M Sell
48,637
-950
-2% -$40K 0.19% 122
2024
Q1 		$2.13M Sell
49,587
-427
-0.9% -$17.6K 0.22% 115
2023
Q4 		$1.85M Buy
50,014
+1,901
+4% +$68.2K 0.21% 117
2023
Q3 		$1.74M Buy
48,113
+1,400
+3% +$49.7K 0.23% 111
2023
Q2 		$1.66M Buy
46,713
+13,100
+39% +$470K 0.21% 123
2023
Q1 		$1.2M Buy
33,613
+32,653
+3,401% +$1.14M 0.16% 138
2022
Q4 		$33.7K Hold
960
– – ﹤0.01% 574
2022
Q3 		$28.3K Hold
960
– – ﹤0.01% 589
2022
Q2 		$52.2K Hold
960
– – 0.01% 528
2022
Q1 		$52.3K Hold
960
– – 0.01% 543
2021
Q4 		$52.9K Sell
960
-224
-19% -$11.7K 0.01% 557
2021
Q3 		$56.6K Buy
1,184
+161
+16% +$8.09K 0.01% 506
2021
Q2 		$50.9K Sell
1,023
-719
-41% -$34.5K 0.01% 529
2021
Q1 		$77.7K Sell
1,742
-2,462
-59% -$112K 0.01% 462
2020
Q4 		$193K Sell
4,204
-639
-13% -$29.4K 0.03% 306
2020
Q3 		$228K Buy
4,843
+301
+7% +$15.1K 0.05% 260
2020
Q2 		$232K Buy
4,542
+1
+0% +$51 0.05% 239
2020
Q1 		$215K Sell
4,541
-158
-3% -$8.43K 0.06% 230
2019
Q4 		$276K Buy
4,699
+1
+0% +$56 0.06% 238
2019
Q3 		$251K Hold
4,698
– – 0.06% 256
2019
Q2 		$235K Buy
4,698
+102
+2% +$5.12K 0.06% 267
2019
Q1 		$240K Sell
4,596
-1,119
-20% -$55.9K 0.06% 253
2018
Q4 		$273K Sell
5,715
-239
-4% -$11.8K 0.08% 221
2018
Q3 		$299K Sell
5,954
-7,120
-54% -$362K 0.07% 242
2018
Q2 		$659K Buy
13,074
+2
+0% +$101 0.16% 145
2018
Q1 		$638K Buy
13,072
+208
+2% +$9.69K 0.17% 149
2017
Q4 		$570K Sell
12,864
-800
-6% -$37K 0.15% 154
2017
Q3 		$693K Sell
13,664
-2,160
-14% -$110K 0.2% 119
2017
Q2 		$853K Hold
15,824
– – 0.28% 88
2017
Q1 		$834K Hold
15,824
– – 0.29% 89
2016
Q4 		$762K Buy
15,824
+3,720
+31% +$184K 0.28% 94
2016
Q3 		$653K Buy
12,104
+200
+2% +$11K 0.25% 99
2016
Q2 		$645K Sell
11,904
-1,040
-8% -$54.8K 0.25% 100
2016
Q1 		$656K Buy
+12,944
New +$645K 0.27% 98

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Anchor Investment Management's GSK Position: Q1 2026 in Review

Anchor Investment Management reduced its GSK (GSK) stake by 5.5% in Q1 2026, selling an estimated $106K and leaving 33,440 shares worth $1.85M. The position accounts for 0.15% of the portfolio, ranked #138.

Anchor Investment Management first reported a position in GSK in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.13M in Q1 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Anchor Investment Management held 33,440 shares of GSK worth $1.85M as of Q1 2026.
  • Anchor Investment Management sold 1,950 GSK shares in Q1 2026, an estimated $106K.
  • GSK made up 0.15% of Anchor Investment Management's portfolio in Q1 2026, its #138 holding.
  • Anchor Investment Management first reported a position in GSK in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's GSK position peaked at $2.13M in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.